Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
(si apre in una nuova finestra)
Autori:
Alberto Reale, Arianna Calistri, Jennifer Altomonte
Pubblicato in:
Pharmaceutics, Numero 13, 2025, Pagina/e 2192, ISSN 1999-4923
Editore:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/pharmaceutics13122192
Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
(si apre in una nuova finestra)
Autori:
Dirk M. Nettelbeck, Mathias F. Leber, Jennifer Altomonte, Assia Angelova, Julia Beil, Susanne Berchtold, Maike Delic, Jürgen Eberle, Anja Ehrhardt, Christine E. Engeland, Henry Fechner, Karsten Geletneky, Katrin Goepfert, Per Sonne Holm, Stefan Kochanek, Florian Kreppel, Lea Krutzke, Florian Kühnel, Karl Sebastian Lang, Antonio Marchini, Markus Moehler, Michael D. Mühlebach, Ulrike Naumann, Rom
Pubblicato in:
Viruses, Numero 13/8, 2021, Pagina/e 1420, ISSN 1999-4915
Editore:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/v13081420
Syncytial death mediated by oncolytic rVSV-NDV dynamically activates immunogenic apoptosis and necroptosis in human lung cancer cells
(si apre in una nuova finestra)
Autori:
Fabian Kortum, Nina Hartmann, Alexander Bryan, Sonja Glauß, Jennifer Altomonte
Pubblicato in:
Molecular Therapy Oncology, Numero 33, 2025, Pagina/e 201027, ISSN 2950-3299
Editore:
Elsevier BV
DOI:
10.1016/j.omton.2025.201027
Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma
(si apre in una nuova finestra)
Autori:
Teresa Krabbe, Janina Marek, Tanja Groll, Katja Steiger, Roland M. Schmid, Angela M. Krackhardt, Jennifer Altomonte
Pubblicato in:
Cancers, Numero 13/5, 2021, Pagina/e 1044, ISSN 2072-6694
Editore:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/cancers13051044
Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-I-dependent checkpoint inhibitor immunotherapy
(si apre in una nuova finestra)
Autori:
Janina Marek, Lorenz Hanesch, Teresa Krabbe, Nadia El Khawanky, Simon Heidegger, Jennifer Altomonte
Pubblicato in:
Molecular Therapy - Oncolytics, Numero 30, 2025, Pagina/e 117-131, ISSN 2372-7705
Editore:
Elsevier BV
DOI:
10.1016/j.omto.2023.08.001
A Novel Chimeric Oncolytic Virus Mediates a Multifaceted Cellular Immune Response in a Syngeneic B16 Melanoma Model
(si apre in una nuova finestra)
Autori:
Sonja Glauß, Victoria Neumeyer, Lorenz Hanesch, Janina Marek, Nina Hartmann, Gabriela M. Wiedemann, Jennifer Altomonte
Pubblicato in:
Cancers, Numero 16, 2025, Pagina/e 3405, ISSN 2072-6694
Editore:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/cancers16193405
